Omega Healthcare Investors, Inc. (NYSE:OHI) Position Lifted by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 6.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,830,302 shares of the real estate investment trust's stock after purchasing an additional 240,006 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.42% of Omega Healthcare Investors worth $155,893,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its position in shares of Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 516 shares in the last quarter. Versant Capital Management Inc acquired a new position in Omega Healthcare Investors during the 2nd quarter valued at approximately $26,000. DiNuzzo Private Wealth Inc. acquired a new stake in shares of Omega Healthcare Investors during the third quarter worth about $33,000. V Square Quantitative Management LLC boosted its holdings in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after purchasing an additional 323 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new stake in Omega Healthcare Investors during the 3rd quarter worth about $48,000. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Performance

NYSE OHI traded down $0.02 on Monday, reaching $40.09. The stock had a trading volume of 3,268,980 shares, compared to its average volume of 1,678,270. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock has a market cap of $10.82 billion, a P/E ratio of 29.49, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. The business's 50-day moving average price is $40.62 and its 200 day moving average price is $37.05. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.68%. Omega Healthcare Investors's payout ratio is 197.06%.

Insider Buying and Selling

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on OHI shares. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research note on Monday, August 26th. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective on the stock in a report on Thursday, October 31st. BMO Capital Markets increased their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a "market perform" rating in a research report on Monday, October 7th. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a report on Wednesday, September 4th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.